Patents by Inventor Daniel Edward Beck

Daniel Edward Beck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9796753
    Abstract: N-Substituted indenoisoquinoline compounds, and pharmaceutical formulations of N-substituted indenoisoquinoline compounds are described. Also described are processes for preparing N-substituted indenoisoquinoline compounds. Also described are methods for treating cancer in mammals using the described N-substituted indenoisoquinoline compounds or pharmaceutical formulations thereof.
    Type: Grant
    Filed: April 27, 2016
    Date of Patent: October 24, 2017
    Assignee: Purdue Research Foundation
    Inventors: Mark Stanley Cushman, Daniel Edward Beck
  • Patent number: 9682990
    Abstract: The invention described herein pertains to substituted indenoisoquinoline compounds as described herein, wherein RA, RD, W, X and Y are defined herein, pharmaceutical compositions and formulations comprising the indenoisoquinoline compounds, their synthesis, and methods for their use in the treatment and/or prevention of cancer.
    Type: Grant
    Filed: May 2, 2016
    Date of Patent: June 20, 2017
    Assignee: Purdue Research Foundation
    Inventors: Mark Stanley Cushman, Daniel Edward Beck
  • Publication number: 20160318946
    Abstract: The invention described herein pertains to substituted indenoisoquinoline compounds as described herein, wherein RA, RD, W, X and Y are defined herein, pharmaceutical compositions and formulations comprising the indenoisoquinoline compounds, their synthesis, and methods for their use in the treatment and/or prevention of cancer.
    Type: Application
    Filed: May 2, 2016
    Publication date: November 3, 2016
    Inventors: Mark Stanely Cushman, Daniel Edward Beck
  • Publication number: 20160229888
    Abstract: N-Substituted indenoisoquinoline compounds, and pharmaceutical formulations of N-substituted indenoisoquinoline compounds are described. Also described are processes for preparing N-substituted indenoisoquinoline compounds. Also described are methods for treating cancer in mammals using the described N-substituted indenoisoquinoline compounds or pharmaceutical formulations thereof.
    Type: Application
    Filed: April 27, 2016
    Publication date: August 11, 2016
    Inventors: Mark Stanley Cushman, Daniel Edward Beck